08.11.2018Neuroaspis presented at Neurowoche 2018/DGN Congress in Berlin

Neuroaspis was presented at DGN Congress during Neurowoche 2018, 30/10-3/11 in Berlin. DGN Congress is one of the largest German-speaking medical congresses and one of the three most visited neurological congresses worldwide. https://www.dgn.org/rubrik-dgn/der-dgn-kongress

23.10.2018Neuroaspis was presented at ECTRIMS Berlin 2018

NEUROASPIS® was presented at  ECTRIMS Berlin 2018, the 34th Congress of the European Committee for Treatment and Research of Multiple Sclerosis, which was held between 10-12 October in Berlin. ECTRIMS is the world’s largest annual international conference devoted to basic and clinical research in Multiple Sclerosis.

01.10.2018Aniva International at ECTRIMS Berlin 2018

Aniva International will be exhibiting at ECTRIMS 2018 – 34th Congress of the European Committee for Treatment and Research of Multiple Sclerosis between 10-12 October in Berlin, Germany. We look forward to meeting you there!  – Stand D11


Aniva Int. reached an agreement for the launch of its brand NEUROASPIS (the first supplement with Clinical Study and World Patent for Multiple Sclerosis and related Neurodegenerative diseases) in Czech Republic through a specialized company in health care of patients with neurological disorders. This agreement comes after the launch of Neuroaspis in Slovakia and ongoing discussions in […]

24.05.2017NEUROASPIS among the leading innovations of VITAFOODS EUROPE 2017

NEUROASPIS was awarded as one of the leading innovations in Vitafoods Europe at Poster Presentation area, which  is a unique platform specially designed to showcase excellence in nutritional science, innovation, business and education. Posters cover ground-breaking product innovations within the fields of nutraceutical ingredients, dietary supplements and new technology.